Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Treatment makes a big difference in the life expectancy and quality of life for people with amyloidosis.
Based on the type of amyloidosis you have, you may need one or more of these treatments:
Chemotherapy: This is the backbone of the treatment strategy to control the disease in most patients with AL amyloidosis. Read more about chemotherapy.
Peripheral blood stem cell transplant: Our physicians use this procedure to treat some patients with AL amyloidosis. The new blood stem cells enable you to receive higher doses of chemotherapy.
Organ transplant: Patients with various types of amyloidosis may benefit from an organ transplant, such as heart, liver or kidney transplants. Stanford is one of the leading centers in the world for heart transplantation in people who have amyloidosis.
Clinical trials: Stanford researchers are testing new potential treatments for multiple types of amyloidosis in our clinical trials. Our physicians can determine if you are eligible to participate in one of our trials.
Because amyloidosis is such a rare disease, it is important to find an amyloid treatment center with an experienced team and specially trained physicians. At the Stanford Amyloid Center, our team is dedicated to expert care and treatment for our patients with all types of amyloidosis.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.